Kris E Gaston
Overview
Explore the profile of Kris E Gaston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinks A, Holck H, McGrath L, Zeng L, Gaston K, Riggs S, et al.
Urol Pract
. 2024 Jun;
11(4):736-744.
PMID: 38899655
Introduction: Previous literature suggests socioeconomic status and racial disparities impact management decisions for patients with small renal masses. We aim to build upon these findings and examine how these modalities...
2.
Sinks A, Holck H, McGrath L, Zeng L, Gaston K, Riggs S, et al.
Urol Pract
. 2024 Jun;
11(4):744.
PMID: 38899648
No abstract available.
3.
Ivan S, Roebuck E, Sinks A, Robinson M, Clark P, Gaston K, et al.
Urol Oncol
. 2024 May;
42(10):332.e1-332.e9.
PMID: 38735799
Introduction: The effect of individual non-narcotic analgesics in cystectomy enhanced recovery after surgery (ERAS) is unknown. Additionally, many non-narcotic medications are associated with side effects pertinent to the cystectomy population....
4.
Ivan S, Holck H, Robinson M, Shea R, Wallander M, Parker B, et al.
Urol Oncol
. 2023 Jul;
41(10):432.e1-432.e9.
PMID: 37455232
Objectives: Opioid use, misuse, and diversion is of paramount concern in the United States. Radical cystectomy is typically managed with some component of opioid pain control. We evaluated persistent opioid...
5.
Kearns J, Matulay J, Anderson W, Hetherington T, Grigg C, Zhu J, et al.
Urol Pract
. 2023 May;
8(6):619-623.
PMID: 37145508
Introduction: 5-Alpha reductase inhibitor (5-ARI) use leads to a 50% decline in serum prostate specific antigen (PSA) without a concomitant decrease in prostate cancer (PCa) risk. We hypothesize that failure...
6.
Patel S, Hensel C, He J, Worrilow W, Gaston K, Kearns J, et al.
Urol Pract
. 2023 May;
8(1):88-93.
PMID: 37145434
Introduction: For muscle invasive bladder cancer, computerized tomography scans are often used before cystectomy to optimize surgical decision planning. The aim of this study is to evaluate the clinical value...
7.
Roebuck E, Ivan S, Robinson M, Worrilow W, Gaston K, Matulay J, et al.
Urol Oncol
. 2022 Jun;
40(8):383.e23-383.e29.
PMID: 35752565
Introduction And Objective: Enhanced Recovery After Surgery (ERAS) protocols have been increasingly applied to urologic surgeries such as cystectomy and prostatectomy, though research defining protocols and outcomes for renal ERAS...
8.
Roebuck E, Sha W, Lu C, Miller C, Burgess E, Grigg C, et al.
Urology
. 2022 Jan;
163:156-163.
PMID: 34995563
Objective: To evaluate whether racial disparities in MRI-Bx usage persisted after correction for socioeconomic, demographic, and clinical factors. Methods: This is a retrospective cohort study of patients who received either...
9.
Roebuck E, Beano H, Robinson M, Edwards D, Worrilow W, Sinks A, et al.
Urology
. 2021 Dec;
161:135-141.
PMID: 34864053
Objective: To study the effect of surgeon-administered Transversus Abdominis Plane block (sTAP) on opioid usage and length of stay (LOS). Methods: Starting in April 2018, two surgeons at our institution...
10.
Sanders J, Frasier C, Matulay J, Steuerwald N, Zhu J, Grigg C, et al.
Transl Androl Urol
. 2021 Aug;
10(7):2998-3009.
PMID: 34430403
Background: Intravesical bacillus Calmette-Guérin (BCG) therapy is standard treatment for high-risk non-muscle invasive bladder cancer (NMIBC) but overall efficacy is low, and no reliable predictive biomarkers currently exist to refine...